Vireo Growth (VREOF) Gross Margin Growth (1y) (2021 - 2026)
Vireo Growth (VREOF) Gross Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.41 Bn | 2.15 Bn | 164.00 |
| 3 | Zoetis | 31.50 Bn | 29.83 Bn | 1.05 Bn | -378.00 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -397.00 |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | -173.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 156.00 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -92.00 |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 88.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Vireo Growth | 491.44 Mn | 349.14 Mn | 95.30 Mn | 312.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 523.00 |
| Dec 31, 2025 | 387.00 |
| Sep 30, 2025 | -819.00 |
| Jun 30, 2025 | -1,149.00 |
| Mar 31, 2025 | -22.00 |
| Dec 31, 2024 | 69.00 |
| Sep 30, 2024 | -451.00 |
| Jun 30, 2024 | 777.00 |
| Mar 31, 2024 | 96.00 |
| Dec 31, 2023 | 515.00 |
| Sep 30, 2023 | 290.00 |
| Jun 30, 2023 | -295.00 |
| Mar 31, 2023 | 3,396.00 |
| Dec 31, 2022 | 2,894.00 |
| Sep 30, 2022 | 1,232.00 |
| Jun 30, 2022 | 58.00 |
| Mar 31, 2022 | -2,666.00 |
| Dec 31, 2021 | -2,692.00 |
| Sep 30, 2021 | -153.00 |
| Jun 30, 2021 | 1,918.00 |